주메뉴 바로가기 본문 바로가기
홈 재단소개 전문의

전문의

GC Labs의 전문의를 소개합니다.

허주영 Jooryung Huh
이전

서울대학교대학원 병리학 박사 (1997)

서울대학교대학원 병리학 석사 (1995)

서울대학교 의학사 (1981)

 

GC녹십자의료재단 병리학본부 원장 (2023~)

GC녹십자의료재단 병리학본부 전문의 (2022)

대한병리학회 이사 (2015~)
한일림프망내계 회장 (2013~2015)
대한병리학회 혈액병리 연구회 대표 (2013~2015)
대한병리학회 혈액병리 연구회 총무 (2011~2013)
울산대 의과대 의학과 진단병리학교실 교수 (2005~2021)
서울아산병원 진단병리과 의사 (2002~2021)
울산대 의과대 의학과 진단병리학교실 부교수 (2000~2005)
울산대 의과대 의학과 진단병리학교실 조교수 (1996~2000)
울산대 의과대 의학과 진단병리학교실 전임강사 (1994~1996)
미국 뉴저지 St. Joseph"s Hospital & Medical Center 병리과, Attending Pathologist (1988~1990)
미국 성요셉병원 겸임교수 (1988~1990)
미국 Blood banking & Surgical Pathology UMDNJ, Newark, NJ 전임의 (1986~1988)
미국 뉴저지 성바르나바스병원 병리과전공의 (1983~1986)

  • Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma
    2023Human Pathology허주영
  • Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma
    2021Sci Rep허주영
  • A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels
    2021Br J Haematol허주영
  • Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis
    2021Blood Adv허주영
  • The limited role of comprehensive staging work-up in ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALToma) with excellent prognosis.
    2021Br J Haematol허주영
  • Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution.
    2021J Pathol Transl Med허주영
  • Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.
    2021Cancer Res Treat허주영
  • Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma.
    2021Oncoimmunology허주영
  • Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.
    2021Blood Adv허주영
  • Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
    2020Sci Rep허주영
  • Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma.
    2020Front Oncol허주영
  • Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma
    2020Leuk Lymphoma허주영
  • JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma.
    2020Ann Lab Med허주영
  • Breast implant-associated anaplastic large cell lymphoma: the first South Korean case.
    2020J Pathol Transl Med허주영
  • A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL
    2020Blood Adv허주영
  • Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities.
    2020Mod Pathol허주영
  • Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents.
    2020Mol Cancer Res허주영
  • XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.
    2020J Hematol Oncol허주영
  • Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
    2019BMC Cancer허주영
  • Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma.
    2019Blood Res허주영
  • Follicular lymphoma with prominent Dutcher body formation after liver transplantation
    2019Blood Res허주영
  • Endoscopic features and clinical outcomes of colorectal mucosa-associated lymphoid tissue lymphoma.
    2018Gastrointest Endosc허주영
목록